Trial of Combination Tumor Treating Fields (TTF; Optune), Nivolumab Plus/Minus Ipilimumab for Recurrent Glioblastoma
Clinical trial NCT03430791 · TERMINATED
Trial details
- NCT number
- NCT03430791
- Sponsor
- Baptist Health South Florida
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-05
- Primary completion
- 2020-05-29
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.